NCT02487459 2020-10-05Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic MalignanciesBellicum PharmaceuticalsPhase 1 Withdrawn
NCT03807063 2020-08-14Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantFred Hutchinson Cancer CenterPhase 1 Withdrawn